A team of researchers led by Himisha Beltran, M.D., discovered the genetic, epigenetic and molecular features that underlie neuroendocrine prostate cancer. Read more
Long a pillar of cancer care, radiation is being used in a new way - to trigger a set of immune responses that converts tumors into internal vaccines. Read more
Manish Shah, M.D., discusses a trial into the use of a STAT3 inhibitor with chemotherapy to curtail stem cell regeneration and reduce recurrence or metastasis in gastric cancer. Read more
Researchers exploring the PI3K pathway have discovered a previously unidentified link between a cancer cell's form and shape and its metabolic capabilities Read more
The Meyer Cancer Center has joined the nation's top cancer centers calling for increased human papillomavirus (HPV) vaccination for the prevention of cancer. Read more
Adding oxaliplatin to fluoropyrimidine-based adjuvant chemotherapy significantly reduces the risk of recurrence of colon cancer, according to Manish Shah, M.D. Read more
Ching-Hsuan Tung, Ph.D., has developed a fluorescent “cancer spray” that can be applied to the ovaries and other organs during surgery to create a luminous outline of cancerous cell clusters. Read more
New prostate cancer treatments could provide hope for those with a rare form of endocrine cancer, according to findings from a team of Meyer researchers led by Thomas Fahey III, M.D. Read more
John Babich, Ph.D., has developed a protocol that combines radiopharmaceuticals and PET scans to improve detection and patient management in prostate cancer. Read more
Claudia Fischbach-Teschl, Ph.D., and Cynthia Reinhart-King, Ph.D., have been elected to the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows. Read more